| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
23,789,000 |
| Market
Cap: |
713.67(K) |
| Last
Volume: |
1,497,358 |
Avg
Vol: |
1,493,289 |
| 52
Week Range: |
$0.03 - $0.03 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ImmunoCellular Therapeutics is a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of cancers. Co.'s clinical product candidates include: ICT-107, which is a dendritic cell (DC) immunotherapy for the treatment of newly diagnosed glioblastoma multiforme, a lethal type of brain cancer; ICT-140, which is a DC immunotherapy that targets seven tumor-associated antigens expressed on ovarian cancer cells; and ICT-121, which specifically targets CD133, a cancer stem cell marker that is in a variety of solid tumors, including ovarian, pancreatic, and breast cancers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cowell Richard |
Director |
– • – |
2013-11-25 |
4 |
AS |
$3.02 |
$181,543 |
D/D |
(55,301) |
10,000 |
|
- |
|
| Cowell Richard |
Director |
– • – |
2013-11-25 |
4 |
OE |
$1.30 |
$73,406 |
D/D |
55,301 |
40,301 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-11-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
32,613 |
32,613 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-11-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
32,613 |
10,000 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-11-25 |
4 |
OE |
$0.25 |
$8,153 |
D/D |
32,613 |
42,613 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-10-21 |
4 |
AS |
$2.92 |
$105,080 |
I/I |
(36,006) |
0 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-10-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
36,006 |
36,006 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-10-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
36,006 |
10,000 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-10-21 |
4 |
OE |
$0.25 |
$9,002 |
D/D |
36,006 |
46,006 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-10-18 |
4 |
AS |
$2.85 |
$92,875 |
I/I |
(32,613) |
0 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-10-18 |
4 |
AS |
$2.91 |
$673,226 |
I/I |
(231,381) |
0 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-10-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
231,381 |
231,381 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-10-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
231,381 |
10,000 |
|
- |
|
| Yu John S |
Secretary |
• • – |
2013-10-18 |
4 |
OE |
$0.25 |
$57,845 |
D/D |
231,381 |
241,381 |
|
- |
|
| Bender James G. |
VP, Product Development & Mfg. |
• – – |
2013-08-29 |
4 |
S |
$3.00 |
$2,700 |
D/D |
(900) |
100 |
|
- |
|
| Bender James G. |
VP, Product Development & Mfg. |
• – – |
2013-08-28 |
4 |
S |
$2.84 |
$38,014 |
D/D |
(13,303) |
1,000 |
|
- |
|
| Bender James G. |
VP, Product Development & Mfg. |
• – – |
2013-08-28 |
4 |
D |
$2.98 |
$19,000 |
D/D |
(6,376) |
14,303 |
|
- |
|
| Bender James G. |
VP, Product Development & Mfg. |
• – – |
2013-08-28 |
4 |
OE |
$0.95 |
$19,000 |
D/D |
20,000 |
20,679 |
|
- |
|
| Bender James G. |
VP, Product Development & Mfg. |
• – – |
2012-06-01 |
4/A |
S |
$3.59 |
$25,191 |
D/D |
(7,000) |
679 |
|
- |
|
| Bender James G. |
VP Product Development & Mfg. |
• – – |
2012-06-01 |
4 |
S |
$3.59 |
$25,191 |
D/D |
(7,000) |
879 |
|
- |
|
| Bender James G. |
VP, Product Development & Mfg. |
• – – |
2012-05-31 |
4 |
S |
$3.92 |
$27,444 |
D/D |
(7,000) |
7,679 |
|
- |
|
| Brandwynne Jacqueline |
Director |
– • – |
2012-05-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
22,000 |
|
- |
|
| Bender James G. |
VP, Product Development & Mfg. |
• – – |
2012-05-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,679 |
|
- |
|
| Singh Manish |
President & CEOOfficer |
• • – |
2012-05-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
907,000 |
|
- |
|
| Cowell Richard |
Director |
– • – |
2012-05-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
54 Records found
|
|
Page 2 of 3 |
|
|
